☆ 4.7 Article

Design and Evaluation of a Novel Peptide-Drug Conjugate Covalently Targeting SARS-CoV-2 Papain-like Protease

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide

Na Liu et al.

Summary: Anti-apoptotic BCL-2 family proteins are important targets for cancer treatment, and targeting the BH3-binding pockets can reactivate apoptosis. A novel sulfonium-tethered peptide cyclization strategy was developed to selectively bind to the cysteine(s) of target proteins, leading to the successful construction of a BFL-1 peptide inhibitor, B4-MC, showing promising growth inhibition of BFL-1 over-expressed cancer cell lines.

CHEMBIOCHEM (2021)

Add to Collection

Review Gastroenterology & Hepatology

COVID-19: Discovery, diagnostics and drug development

Tarik Asselah et al.

Summary: COVID-19 started in Wuhan in 2019 and has become a global pandemic. The virus responsible, SARS-CoV-2, shares a high sequence identity with bat- and pangolin-derived coronaviruses. Risk factors for SARS-CoV-2 infection include age, obesity, diabetes, and hypertension.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Microbiology

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu et al.

Summary: This review summarizes the research progress on SARS-CoV-2 and COVID-19, including virology characteristics, pathogenesis, and recent advances in treatment methods. Furthermore, it discusses in detail the potential wildlife hosts and zoonotic origin of this emerging virus.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Discovery of small molecule PLpro inhibitor against COVID-19 using structure-based virtual screening, molecular dynamics simulation, and molecular mechanics/Generalized Born surface area (MM/GBSA) calculation

Jie Pang et al.

Summary: COVID-19 is a global pandemic with urgent need for effective treatments. Researchers identified four potential PLpro inhibitors through virtual screening, molecular dynamics simulations, and energy calculation approaches, which may serve as promising chemical scaffolds for combating COVID-19.

STRUCTURAL CHEMISTRY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Crystal structure of SARS-CoV-2 papain-like protease

Xiaopan Gao et al.

Summary: This study provided structural frameworks for PLpro inhibitor design targeting SARS-CoV-2, showing that existing SARS-CoV PLpro inhibitors have some efficacy against SARS-CoV-2 and explored the inhibition mechanism of GRL0617.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Review Medicine, Research & Experimental

COVID-19 challenges and its therapeutics

Sabi Ur Rehman et al.

Summary: COVID-19 has emerged as a major cause of death worldwide, prompting extensive research into therapeutic options including drug repurposing and repositioning, as well as exploration of various medications and medicinal plants for potential treatment. Vaccine development is also underway, with concerns about SARS-CoV-2 variants impacting vaccine effectiveness.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Article Medicine, General & Internal

Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results

Summary: The authors of the study reported the interim results of using four repurposed antiviral drugs (remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a) in hospitalized COVID-19 patients. The study showed that these drug regimens had little or no effect on overall mortality, initiation of ventilation, and duration of hospital stay.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review

Hadis Fathizadeh et al.

Summary: The development of COVID-19 vaccines is aimed at preventing the spread of the disease globally, with some vaccines showing high levels of safety and protection. However, comparing different vaccines is not easy without a unified standard for measuring neutralization.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease

Yunxia Xu et al.

Summary: COVID-19 has spurred global efforts to develop specific drugs, with papain-like protease (PLpro) as an attractive drug target due to its essential functions. Two potential PLpro inhibitors were discovered through screening techniques, highlighting their usefulness in drug development.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Add to Collection

Article Multidisciplinary Sciences

The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery

Ziyang Fu et al.

Summary: SARS-CoV-2 PLpro enzyme plays a critical role in virus maturation, host inflammation regulation, and antiviral immune responses, making it a promising drug target. The inhibitor GRL0617 has shown to effectively inhibit PLpro and has promising antiviral activity in vitro. This study provides insights into the mechanism of action of GRL0617 and highlights the potential of targeting the PLpro enzyme for antiviral drug discovery.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

Mohd Imran et al.

Summary: Molnupiravir, developed initially for influenza treatment, has shown promising activity against various viruses, including SARS-CoV-2. With good safety profile and oral bioavailability, it is currently in development for treating COVID-19 and expected to be available in an oral dosage form in 2022. Patent data suggests potential combinations with other drugs to enhance efficacy.

MOLECULES (2021)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Decoding molnupiravir-induced mutagenesis in SARS-CoV-2

Luis Menendez-Arias

Summary: Molnupiravir can be incorporated into viral RNA and used as template for RNA synthesis, leading to error catastrophe in SARS-CoV-2.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies

Renuka Raman et al.

Summary: SARS-CoV-2 is the cause of the COVID-19 pandemic, with its variants posing challenges to containment efforts. Individuals with dysregulated immune response and comorbidities are more susceptible to infection, and research on various vaccines and treatments is ongoing to address this challenge.

BIOMOLECULES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2

Fangfang Yan et al.

Summary: There is an urgent need for effective treatments for COVID-19 caused by SARS-CoV-2. Despite extensive research, effective treatment strategies are still lacking.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Add to Collection

Review Public, Environmental & Occupational Health

An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know?

Hanieh Beyrampour-Basmenj et al.

Summary: COVID-19 is an infectious respiratory disease caused by the novel coronavirus, officially declared as a pandemic by the World Health Organization in March 2020. As of now, there is no definitive cure, but countries have started emergency use of vaccines for prevention.

PUBLIC HEALTH REVIEWS (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)

Dae-Gyun Ahn et al.

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

Donghyuk Shin et al.

NATURE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2

Theresa Klemm et al.

EMBO JOURNAL (2020)

Add to Collection

Article Multidisciplinary Sciences

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design

Wioletta Rut et al.

SCIENCE ADVANCES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Peptide-Drug Conjugate: A Novel Drug Design Approach

Liang Ma et al.

CURRENT MEDICINAL CHEMISTRY (2017)

Add to Collection

Review Pharmacology & Pharmacy

Peptide-drug conjugates as effective prodrug strategies for targeted delivery

Yin Wang et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Add to Collection

Article Virology

MERS-CoV papain-like protease has deISGylating and deubiquitinating activities

Anna M. Mielech et al.

VIROLOGY (2014)

Add to Collection

Review Cell Biology

The Ubiquitin-Conjugating System: Multiple Roles in Viral Replication and Infection

Arianna Calistri et al.

CELLS (2014)

Add to Collection

Article Multidisciplinary Sciences

A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

Kiira Ratia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Add to Collection

Article Virology

Identification of a novel cleavage activity of the first papain-like proteinase domain encoded by open reading frame 1a of the coronavirus Avian infectious bronchitis virus and characterization of the cleavage products

KP Lim et al.

JOURNAL OF VIROLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.